Moreover, allicin 30 and 60 μg/mL has a potential anticancer effect against Glioblastoma (GBM), since it slows the growth and causes apoptosis in glioma cells in vitro by activating both intrinsic mitochondrial and extrinsic Fas/FasL-mediated pathways [63]. The gene discussed is FAS; the disease is glioblastoma.